Training activity information

Details

Interpret immunological data in light of patient history and associated laboratory results, patients with secondary immunodeficiency, including all of the following:

  • Iatrogenic
  • Neoplasia
  • Infection

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

  • Guidance documents
  • Reference ranges and interpretation and limitations of tests
  • Sources of interference/cross-reactivity
  • Pathway/process for urgent cases
  • Implications for patient outcome
  • Effect of comorbidities and therapy on interpretation of results
  • Confirmatory testing

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

  • What knowledge of how these three categories can impact the immune system is required? What aspects of the patient’s history and other laboratory information  will be particularly important?
  • What is your current understanding of secondary immunodeficiencies and their diverse causes? What challenges might you face in attributing immunological findings to a specific underlying cause of secondary immunodeficiency, and how will you approach this?
  • How will you prepare for interpreting this data? Will you review the mechanisms of immunosuppression in these contexts, the typical immunological findings, and relevant case examples for each category? Will you consider how to differentiate primary from secondary immunodeficiency based on laboratory data and clinical history?

In action

  • As you review the patient history, what factors related to iatrogenic causes, neoplasia, or infection are you noting that could be contributing to secondary immunodeficiency?
  • How are you differentiating the immunological changes due to the underlying condition from potential primary immune defects as you interpret the data?
  • Are there specific patterns in the immunological results that are more indicative of a secondary rather than a primary immunodeficiency in this case?

On action

  • For each of the three scenarios (iatrogenic, neoplasia, infection), summarise the key immunological data, patient history , and associated laboratory results. What were the characteristic changes in the immune profile associated with each cause of secondary immunodeficiency? How did the clinical context help in interpreting the immunological findings?
  • What did you learn about how different underlying conditions or treatments can impact the immune system, leading to secondary immunodeficiency? Were there any overlaps or complexities in the immunological profiles? Why is it important to consider the possibility of secondary immunodeficiency when interpreting immunological data?
  • What specific causes of secondary immunodeficiency and their immunological manifestations would you like to learn more about? What resources or discussions with clinical colleagues could further your understanding in this area?

Beyond action

  • Have you since interpreted data from patients with secondary immunodeficiencies arising from iatrogenic causes, neoplasia, or infection?
  • How has this experience improved your ability to differentiate between primary and secondary immunodeficiencies?

Relevant learning outcomes

# Outcome
# 2 Outcome

Interpret and report on laboratory investigations that enumerate components of this immune system and its function in light of clinical details and other laboratory tests.

# 3 Outcome

Identify and escalate urgent abnormal test results and report urgent abnormal results to the requesting healthcare professional, according to local protocols.